Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

<< Previous

Bullboard Posts

Next >>

Post by RazeKreationson Mar 31, 2022 1:46pm

178 Views

Post# 34563875

Big gains coming for DxVtm

Should start seeing substantantial improvements in customer base and orders by end of this fiscal year
For DxTM, complete automation for primary SKU, build-out our product-line to

include other types of DxTM, and add more large customers ex-Ontario.
(Federal government,other Provinces, Hospitals Etc )

Our DxTM has become the

mainstay for MDx testing in

Ontario, and we will add new

SKUs to this product-line.

With DxTM, we’ve built trust

with Govt. procurement

agents, and added to our

clinical lab offerings.

Our range of customers now

even includes, mine-sites,

film production companies,